Northcape Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $609K | Sell |
13,145
-85
| -0.6% | -$3.94K | 0.19% | 91 |
|
|
2025
Q1 | $807K | Buy |
13,230
+3,293
| +33% | +$201K | 0.26% | 75 |
|
|
2024
Q4 | $562K | Buy |
9,937
+3,860
| +64% | +$218K | 0.18% | 92 |
|
|
2024
Q3 | $314K | Sell |
6,077
-649
| -10% | -$33.6K | 0.1% | 112 |
|
|
2024
Q2 | $279K | Buy |
6,726
+254
| +4% | +$10.5K | 0.1% | 118 |
|
|
2024
Q1 | $351K | Sell |
6,472
-212
| -3% | -$11.5K | 0.13% | 102 |
|
|
2023
Q4 | $343K | Buy |
6,684
+402
| +6% | +$20.6K | 0.12% | 113 |
|
|
2023
Q3 | $365K | Buy |
6,282
+3,045
| +94% | +$177K | 0.14% | 110 |
|
|
2023
Q2 | $207K | Buy |
3,237
+220
| +7% | +$14.1K | 0.07% | 144 |
|
|
2023
Q1 | $209K | Buy |
+3,017
| New | +$209K | 0.08% | 145 |
|
|
2022
Q4 | – | Sell |
-5,567
| Closed | -$396K | – | 80 |
|
|
2022
Q3 | $396K | Buy |
5,567
+2,350
| +73% | +$167K | 0.14% | 103 |
|
|
2022
Q2 | $248K | Sell |
3,217
-2,080
| -39% | -$160K | 0.09% | 111 |
|
|
2022
Q1 | $387K | Buy |
5,297
+2,080
| +65% | +$152K | 0.11% | 113 |
|
|
2021
Q4 | $201K | Buy |
+3,217
| New | +$201K | 0.07% | 131 |
|